期刊文献+

荷瘤裸鼠膀胱癌原位模型的建立 被引量:2

Establishing the bearing cancer model of situ bladder cancer in nude mice
下载PDF
导出
摘要 目的通过细胞移植法建立模拟人的膀胱原位癌荷瘤裸鼠模型,为临床膀胱癌的防治提供新的思路。方法将人膀胱移行细胞癌株T24原位移植到裸鼠膀胱内后定期用磁共振成像(MRI)检测,并进行解剖,组织病理学和免疫细胞学检查。结果裸鼠膀胱内的癌发生率为94.0%(47/50),组织病理学检查:Ⅰ级23例,Ⅱ级15例,Ⅲ级9例,免疫细胞学证实该模型具有人膀胱移行细胞癌株T24的特性。结论模拟人的荷瘤裸鼠膀胱癌原位模型符合临床上膀胱肿瘤向膀胱内生长的过程,具有很强的实用性。 Objective To establish bearing cancer model of analogue hominal situ bladder cancer in nude mice by cellular transplant method to further explore the genesis and development basic mechanism of bladder tumor and offer some new ideas for its prevention and treatment. Methods After T24 strain ( human bladder transitional cell carcinoma strain) situ transplanting in nude mice bladder, MRI examination was carried out regularly and the anatomy, histopathologic and immunocytologic examinations were conducted simultaneously. Results The overall tumor establishment was 94. 0% (47/50), histopathologic examination showed 23 cases of grade Ⅰ , 15 grade Ⅱ and 9 grade Ⅲ. The immunocytology showed that the model had the characteristics of human bladder transitional cell carcinoma strain T24. Condusions The bearing cancer model of analogue hominal situ bladder cancer in nude mice is better coincident with the ingrowing to bladder process of clinical bladder cancer, which has much more practicability.
出处 《中国老年学杂志》 CAS CSCD 北大核心 2007年第9期827-828,共2页 Chinese Journal of Gerontology
基金 吉林省科技厅资助项目(200505118)
关键词 原位裸鼠模型 人移行细胞癌株T24 Situ model of nude mice Human bladder transitional cell carcinoma strain T24
  • 相关文献

参考文献4

  • 1Torti SV,Golden-Fleet M,Willingham MC,et al.Use of green florescent protein to measure tumor growth in an implanted bladder tumor model[J].J Urol,2002 ;167:724-8.
  • 2Asanuma H,Arai T,Sequchi K,et al.Successful diagnosis of orthotopic rat superficial bladder tumor model by ultrathin cystoscopy[J].J Urol,2003; 169:718-20.
  • 3Xiao Z,Mccallum TJ,Brown KM,et al.Characterization of a novel transplantable orthotopic rat bladder transitional cell tumor model[J].Br J Cancer,1999 ;81:638-46.
  • 4Cozzi PJ,Malhotra S,Mcauliffe P,et al.Intravesical oncolytic viral therapy using attenuated replication-competent,herpes simplex viruses G207 is effective in the treatment of bladder cancer in an orthotopic syngeneic model[J].FASEB J,2001 ;15:1306-9.

同被引文献27

  • 1孙亚欣,张志超,孙立群,高洪文.基质金属蛋白酶含量及表达与膀胱癌侵袭转移的关系[J].吉林大学学报(医学版),2005,31(1):127-129. 被引量:9
  • 2Henriquez-Hernandez LA, Navarro P, Luzardo OP, et al. Polymorphisms of glutathione S-transferase mu and theta, MDR1 and VEGF genes as risk factors of bladder cancer: a casrcontrol study [J]. Urol Oncol, 2012, 30 (5): 660- 665.
  • 3Biselli-Chicote PM, Oliveira AR, Pavarino EC, et al. VEGF gene alternative splicing: pro- and anti-angiogenic isoforms in cancer [J]. J Cancer Res Clin Oncol, 2012, 138 (3): 363- 370.
  • 4Bates DO, Cui TG, Doughty JM, et al. VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma [J]. Cancer Res, 2002, 62 (14): 4123-4131.
  • 5Josep T, Geoffrey IS, Patricia ML, et al. First-in-humans trail of an RNA interference therapeutic targeting VEGF and KSP in cancer patients with liver involvement[J]. Cancer Discov, 2013, 3 (4): 406-417.
  • 6Perrot-Applanat M. VEGF isoforms [J]. Cell Adh Migr, 2012, 6 (6): 526-527.
  • 7Sitohy B, Nagy JA, Dvorak HF. Anti-VEGF/VEGFR therapy for cancer: reassessing the target [J]. Cancer Res, 2012, 72 (8): 1909-1914.
  • 8Woolard J, Wang WY, Bevan HS, et al. VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression [J]. Cancer Res, 2004, 64 (21): 7822-7835.
  • 9Rennel E, Waine E, Guau H, et al. The endogenous anti- angiogenic VEGF isoform, VEOF165b inhibits human tumour growth in mice [J]. Br J Cancer, 2008, 98 (7): 1250-1257.
  • 10Merdad A, Karim S, Schulten HJ, et al. Expression of matrix metalloproteinases (MMPs) in primary human breast cancer: MMP-9 as a potential biomarker for cancer invasion and metastasis [J]. Anticancer Res, 2014, 34 (3): 1355- 1366.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部